Funds advised by European mid-market private equity firm Triton have agreed to sell BlitzLuxCo, the holding company of pharmaceutical packaging producer Bormioli Pharma Group, to Gerresheimer, a systems and solutions provider for the pharma, biotech and cosmetics industries.
The transaction is expected to close in Q4 2024.
Triton acquired Bormioli in 2017 via a corporate carveout. In a press statement, the firm said that it had helped improve Bormioli’s management team, organisational and operational structure, as well as expand the company’s manufacturing base and oversee four acquisitions.
Andrea Lodetti, CEO of Bormioli Pharma Group, added that the company had been “able to build out our positions across pharma packaging, with one-stop-shop capabilities in terms of technology as well as product offering” during Triton’s ownership.
BNP Paribas and Goldman Sachs International acted as M&A financial advisors.
Source: Private Equity Wire
Can’t stop reading? Read more
Carlyle edges ahead in €6bn pursuit of BASF’s coatings division
Carlyle edges ahead in €6bn pursuit of BASF’s coatings division Carlyle Group has emerged as the...
CVC expands US footprint with $1.75bn acquisition of data-driven insurer Bamboo
CVC expands US footprint with $1.75bn acquisition of data-driven insurer Bamboo CVC Capital...
Bain Capital closes $14bn flagship buyout fund, topping $10bn target
Bain Capital closes $14bn flagship buyout fund, topping $10bn target Bain Capital has completed...